Kestra Medical Technologies, Ltd. Common Stock KMTS Ratios & Valuation
| FY'25 | ||
|---|---|---|
| Profitability | ||
| Gross margin | 40.5%+39.2pp | |
| Operating margin | -177.8%+128pp | |
| Net margin | -190.3%+148pp | |
| EBITDA margin | -164.5%+99.7pp | |
| Free cash flow margin | -168.1%+136pp | |
| Returns | ||
| Return on assets | -66.6%— | |
| Efficiency | ||
| Asset turnover | 0.4×— | |
| Liquidity | ||
| Current ratio | 6.7×+6.3× | |
| Quick ratio | 6.7×+6.3× | |
| Cash ratio | 6.3×+6.0× | |
| Leverage | ||
| Debt-to-assets | 0.1×-0.8× | |
| Interest coverage | -13.8×-0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) runs a 48.8% gross margin and a -171.5% operating margin, with a -173.0% net margin.
- Where do Kestra Medical Technologies, Ltd. Common Stock's ratios come from?
- Every ratio is computed from Kestra Medical Technologies, Ltd. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
